Skip to content
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Genmab
  4. Genmab — September 2024

Genmab — September 2024

Planlagt Fastgjort Låst Flyttet Genmab
1.1k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • BulderB Offline
    BulderB Offline
    Bulder
    wrote on sidst redigeret af
    #990

    Jo jo, men det vidste vi jo at Perseus og Cepheus havde stærke data. Erzotabart i combi er vi slet ikke nået til endnu. H2H studiet er kun mono for begge stoffer. Hvis bare erzo er dara overlegent i mono og hvis sikkerhedsprofilen er god, så er der ingen tvivl om at erzo i kombi også bliver overlegen.

    1 Reply Last reply
    0
    • L Offline
      L Offline
      lahn1
      wrote on sidst redigeret af
      #991

      LOL for helvede Bulder !! sidder og får et chok over en ny Dara udfordre, som jeg ikke kender. panik !!! over på chat gpt ved ikke noget så googler jeg og hvad f.. det er jo bare Gen3014 😄 god weekend

      1 Reply Last reply
      0
      • BulderB Offline
        BulderB Offline
        Bulder
        wrote on sidst redigeret af
        #992

        Yes, hexabody cd38 = erzotabart. Man ændrede måden at navngive antistoffer på i 2021. The revised system was approved and adopted by the WHO at the 73rd INN Consultation held in October 2021, and the radical decision was made to discontinue the use of the well-known stem -mab in naming new antibody-based drugs and going forward, to replace it with four new stems: -tug, -bart, -mig, and -ment.

        1 Reply Last reply
        0
        • BulderB Offline
          BulderB Offline
          Bulder
          wrote on sidst redigeret af
          #993

          https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122354/

          1 Reply Last reply
          0
          • BulderB Offline
            BulderB Offline
            Bulder
            wrote on sidst redigeret af
            #994

            Så i stedet for erzotaMAB, kom hex38 til at hedde erzotaBART.

            1 Reply Last reply
            0
            • BulderB Offline
              BulderB Offline
              Bulder
              wrote on sidst redigeret af
              #995

              Kan være vi her i tjatten skal gå over til det nye navn. Eller bare “erzo” svarende til “dara”

              1 Reply Last reply
              0
              • SolsenS Offline
                SolsenS Offline
                Solsen
                wrote on sidst redigeret af
                #996

                Lyder gangbart 🙂

                1 Reply Last reply
                0
                • SolsenS Offline
                  SolsenS Offline
                  Solsen
                  wrote on sidst redigeret af
                  #997

                  Korrekt at testen er dara vs erzo.

                  1 Reply Last reply
                  0
                  • B Offline
                    B Offline
                    bikube
                    wrote on sidst redigeret af
                    #998

                    JnJ releases encouraging data on Talvey combination therapies, siger S A.

                    1 Reply Last reply
                    0
                    • Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktørH Offline
                      Helge_LarsenPI-redaktør
                      wrote on sidst redigeret af
                      #999

                      Godmorgen. 🙂

                      1 Reply Last reply
                      0
                      • E Offline
                        E Offline
                        E_L
                        wrote on sidst redigeret af
                        #1000

                        DARZALEX® (daratumumab) subcutaneous (SC) formulation-based quadruplet regimen significantly improves minimal residual disease negativity for newly diagnosed multiple myeloma patients for whom transplant is not planned https://www.globenewswire.com/en/news-release/2024/09/27/2954641/0/en/DARZALEX-daratumumab-subcutaneous-SC-formulation-based-quadruplet-regimen-significantly-improves-minimal-residual-disease-negativity-for-newly-diagnosed-multiple-myeloma-patients-f.html

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #1001

                          IMS 2024 – Darzalex fights back against Sarclisa https://www.oncologypipeline.com/apexonco/ims-2024-darzalex-fights-back-against-sarclisa

                          1 Reply Last reply
                          0
                          • SolsenS Offline
                            SolsenS Offline
                            Solsen
                            wrote on sidst redigeret af
                            #1002

                            Carvykti med gode 3 års data i second line https://finance.yahoo.com/news/carvykti-first-only-cell-therapy-203000097.html

                            1 Reply Last reply
                            0
                            • SolsenS Offline
                              SolsenS Offline
                              Solsen
                              wrote on sidst redigeret af
                              #1003

                              Vi skal nok huske de ca 60% MRD negative, når vi ser erzo data.

                              1 Reply Last reply
                              0
                              • SolsenS Offline
                                SolsenS Offline
                                Solsen
                                wrote on sidst redigeret af
                                #1004

                                Tillige mange bivirkninger grade 3/4

                                1 Reply Last reply
                                0
                                • E Offline
                                  E Offline
                                  E_L
                                  wrote on sidst redigeret af
                                  #1005

                                  After Sanofi's first-line myeloma nod, J&J strikes back with new tranche of Darzalex data https://www.fiercepharma.com/pharma/after-sanofis-first-line-myeloma-nod-jj-strikes-back-new-tranche-darzalex-data

                                  1 Reply Last reply
                                  0
                                  • E Offline
                                    E Offline
                                    E_L
                                    wrote on sidst redigeret af
                                    #1006

                                    Antibody drug conjugates in recurrent or metastatic cervical cancer: a focus on tisotumab vedotin state of art

                                    Therapeutic Advances in Medical Oncology https://journals.sagepub.com/doi/10.1177/17588359241277647

                                    1 Reply Last reply
                                    0
                                    • G Offline
                                      G Offline
                                      gentogen
                                      wrote on sidst redigeret af
                                      #1007

                                      BI predicts Darzalex sales will hit $14.7 billion by 2030.

                                      1 Reply Last reply
                                      0
                                      • G Offline
                                        G Offline
                                        gentogen
                                        wrote on sidst redigeret af
                                        #1008

                                        BI’s belief Darzalex may fail to hit the heights anticipated by other analysts reflects the assumption that Inflation Reduction Act price cut for Darzalex in 2029 will also impact the newer subcutaneous formulation Darzalex Faspro.

                                        1 Reply Last reply
                                        0
                                        • G Offline
                                          G Offline
                                          gentogen
                                          wrote on sidst redigeret af
                                          #1009

                                          Just a moment...

                                          favicon

                                          (www.fiercepharma.com)

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper